Commave Therap Drug Patent Portfolio

Commave Therap owns 1 orange book drug protected by 6 US patents Given below is the list of Commave Therap's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10584112 Methylphenidate-prodrugs, processes of making and using the same 09 Dec, 2037
Active
US10584113 Methylphenidate-prodrugs, processes of making and using the same 09 Dec, 2037
Active
US10759778 Methylphenidate-prodrugs, processes of making and using the same 09 Dec, 2037
Active
US10858341 Compositions comprising methylphenidate-prodrugs, processes of making and using the same 09 Dec, 2037
Active
US10954213 Compositions comprising methylphenidate-prodrugs, processes of making and using the same 09 Dec, 2037
Active
US9079928 Methylphenidate-oxoacid conjugates, processes of making and using the same 27 Jul, 2032
Active


Given below is the list of recent legal activities going on the following drug patents of Commave Therap.

Activity Date Patent Number
Patent litigations
transaction for FDA Determination of Regulatory Review Period 30 Jan, 2024 US9079928
Payment of Maintenance Fee, 4th Year, Large Entity 31 Dec, 2023 US10759778
Payment of Maintenance Fee, 4th Year, Large Entity 31 Dec, 2023 US10858341
transaction for FDA Determination of Regulatory Review Period 29 Nov, 2023 US9079928
Payment of Maintenance Fee, 4th Year, Large Entity 05 Sep, 2023 US10584112
Payment of Maintenance Fee, 4th Year, Large Entity 05 Sep, 2023 US10584113
Email Notification 17 May, 2023 US9079928
Electronic Review 17 May, 2023 US9079928
Second letter to regulating agency to determine regulatory review period 16 May, 2023 US9079928
Payment of Maintenance Fee, 8th Year, Large Entity 05 Jan, 2023 US9079928
Letter from FDA or Dept of Agriculture re PTE application 28 Sep, 2022 US9079928
Initial letter Re: PTE Application to regulating agency 27 Jan, 2022 US9079928
Patent Issue Date Used in PTA Calculation 23 Mar, 2021 US10954213
Recordation of Patent Grant Mailed 23 Mar, 2021 US10954213
Email Notification 05 Mar, 2021 US10954213


Commave Therap's Family Patents

Commave Therap drugs have patent protection in a total of 28 countries. It's US patent count contributes only to 28.4% of its total global patent coverage. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Commave Therap Drug List

Given below is the complete list of Commave Therap's drugs and the patents protecting them.


1. Azstarys

Azstarys is protected by 6 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10584112 Methylphenidate-prodrugs, processes of making and using the same 09 Dec, 2037
(12 years from now)
Active
US10584113 Methylphenidate-prodrugs, processes of making and using the same 09 Dec, 2037
(12 years from now)
Active
US10759778 Methylphenidate-prodrugs, processes of making and using the same 09 Dec, 2037
(12 years from now)
Active
US10858341 Compositions comprising methylphenidate-prodrugs, processes of making and using the same 09 Dec, 2037
(12 years from now)
Active
US10954213 Compositions comprising methylphenidate-prodrugs, processes of making and using the same 09 Dec, 2037
(12 years from now)
Active
US9079928 Methylphenidate-oxoacid conjugates, processes of making and using the same 27 Jul, 2032
(7 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Azstarys's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List